Impact of Remdesivir on inflammatory and prognostic markers of COVID-19: Findings of an event-monitoring studys

Impact of Remdesivir on inflammatory and prognostic markers of COVID-19: Findings of an event-monitoring studys

Introduction: Remdesivir is currently approved for treating hospitalised patients with COVID-19. However, it is a priority to monitor its safety and effectiveness in various clinical settings. This study was undertaken to assess the impact of remdesivir on inflammatory and prognostic markers of COVI...

Full description

Bibliographic Details
Main Authors: Shruti Singh, Nishi Sinha, Pallavi Lohani, Neha Agarwal, Pratibha Singh, C M Singh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
adverse drug reaction profile
inflammatory biomarkers
prognostic markers
remdesivir
survival analysis
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2023;volume=12;issue=12;spage=3135;epage=3141;aulast=Singh

Internet

http://www.jfmpc.com/article.asp?issn=2249-4863;year=2023;volume=12;issue=12;spage=3135;epage=3141;aulast=Singh

Similar Items